Drug giant Eli Lilly said Wednesday it will slash the cost of its top-selling insulin drugs by 70% as Congress remains stalled on capping prices on the medication vital to millions of Americans ...

An insulin maker is cutting its prices. Eli Lilly, one of the three makers of insulin products in the United States, is also making other moves toward affordability for people with diabetes.

Drugmaker Eli Lilly warned this week that two of its formulations of insulin would be temporarily out of stock through the beginning of April, citing a “brief delay in manufacturing.” ...

The top 3 insulin makers recently announced price cuts. Here’s what to know Eli Lilly, Novo Nordisk and Sanofi all announced plans to cap prices on the diabetes treatment after pressure from ...

Eli Lilly Says It Will Cut the Price of Insulin The company also trumpeted an existing policy that caps monthly out-of-pocket cost for its lifesaving products at $35.

Eli Lilly and Company (NYSE:LLY) is one of the 10 Best Non-Tech Stocks to Buy and Hold For 3 Years. On June 22, Eli Lilly and ...

Eli Lilly said it would cap the out-of-pocket cost of insulin at $35 per month. More than 8 million people with diabetes rely on insulin, which is notoriously expensive in the U.S.

Pharmaceutical giant Eli Lilly said Wednesday it is voluntarily cutting the price of its insulin for all Americans, capping the out of pocket cost for the diabetes treatment at $35 per month or less.

Eli Lilly, one of the largest makers of insulin, said it would make dramatic cuts to the prices of several of its older insulin products in an effort to lower costs for consumers whose insulin is ...

As GLP-1 sales surge, insulin users fear Novo Nordisk and Eli Lilly will leave them in the lurch.

Eli Lilly said 10-milliliter vials of Humalog and insulin lispro Injection would be in short supply through early April.